Artelo Biosciences (ARTL) Earnings Date, Estimates & Call Transcripts $1.11 -0.02 (-1.77%) (As of 11/22/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Artelo Biosciences Latest Earnings SummaryUpcoming Earnings DateMar. 24EstimatedActual EPS (Nov. 12) -$0.35 Beat By $0.06 Consensus EPS (Nov. 12) -$0.41 Artelo Biosciences released Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.35, which topped analysts' consensus estimates of -$0.41 by $0.06. With a trailing EPS of -$2.87, Artelo Biosciences' earnings are expected to grow next year, from ($2.62) to ($1.61) per share. ARTL Upcoming EarningsArtelo Biosciences' next earnings date is estimated for Monday, March 24, 2025, based off prior year's reporting schedules. Get Artelo Biosciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Artelo Biosciences and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataARTL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ARTL Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Artelo Biosciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241-$1.05-$1.05-$1.05Q2 20241-$0.83-$0.83-$0.83Q3 20241-$0.41-$0.41-$0.41Q4 20241-$0.74-$0.74-$0.74FY 20244($3.03)($3.03)($3.03) Artelo Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 3/24/2025(Estimated)------- 11/12/2024--$0.41-$0.35+$0.06-$0.35--8/13/2024Q2 2024-$0.85-$0.75+$0.10-$0.75--5/13/2024--$1.05-$0.78+$0.27-$0.78--3/25/2024Q4 2023-$0.29-$0.99 -$0.70-$0.99--11/13/2023Q3 2023-$0.70-$0.83 -$0.13-$0.83--8/10/2023Q2 2023-$0.93-$0.56+$0.37-$0.56-- Get the Latest News and Ratings for ARTL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Artelo Biosciences and its competitors with MarketBeat's FREE daily newsletter. 5/11/2023Q1 2023-$0.99-$0.76+$0.23-$0.76--3/31/2023Q4 2022-$0.87-$1.18 -$0.31-$1.18-- Artelo Biosciences Earnings - Frequently Asked Questions When is Artelo Biosciences's earnings date? Artelo Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 24th, 2025 based off last year's report dates. Learn more on ARTL's earnings history. Did Artelo Biosciences beat their earnings estimates last quarter? In the previous quarter, Artelo Biosciences (NASDAQ:ARTL) reported ($0.35) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.41) by $0.06. Learn more on analysts' earnings estimate vs. ARTL's actual earnings. How much profit does Artelo Biosciences generate each year? Artelo Biosciences (NASDAQ:ARTL) has a recorded net income of -$9.29 million. ARTL has generated -$2.87 earnings per share over the last four quarters. What is Artelo Biosciences's EPS forecast for next year? Artelo Biosciences's earnings are expected to grow from ($2.62) per share to ($1.61) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies AIM Earnings PMCB Earnings SLGL Earnings WENA Earnings SNSE Earnings AWH Earnings NKGN Earnings TLPH Earnings TSBX Earnings IPA Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. This page (NASDAQ:ARTL) was last updated on 11/24/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | Sponsored#1 Crypto of 2024Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artelo Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Artelo Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
